Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$2.35B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$169M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| RUBINSTEIN JULIE | Mar 5, 2026 | Sell | 30,941 | $16 | $500,000 |
| ROBINS HARLAN S | Mar 3, 2026 | Sell | 14,233 | $16.52 | $240,000 |
| RUBINSTEIN JULIE | Mar 3, 2026 | Sell | 24,423 | $15.49 | $380,000 |
| ROBINS CHAD M | Mar 3, 2026 | Sell | 50,703 | $15.49 | $790,000 |
| GRIFFIN MICHELLE RENEE | Mar 3, 2026 | Sell | 48,044 | $15.3 | $740,000 |
| RUBINSTEIN JULIE | Mar 3, 2026 | Sell | 6,518 | $16.33 | $110,000 |
| ROBINS CHAD M | Mar 3, 2026 | Sell | 2,380 | $16.15 | $38,000 |
| ROBINS CHAD M | Mar 2, 2026 | Sell | 289,024 | $15.82 | $4.6M |
| ROBINS HARLAN S | Mar 2, 2026 | Sell | 10,000 | $15.72 | $160,000 |
| ROBINS CHAD M | Feb 27, 2026 | Sell | 182,891 | $15.99 | $2.9M |
| PISKEL KYLE | Feb 4, 2026 | Sell | 2,145 | $18.46 | $40,000 |
| ROBINS HARLAN S | Feb 3, 2026 | Sell | 8,120 | $19 | $150,000 |
| ROBINS CHAD M | Feb 2, 2026 | Sell | 124,998 | $18.44 | $2.3M |
| ROBINS HARLAN S | Feb 2, 2026 | Sell | 34,668 | $18.6 | $640,000 |
| LO FRANCIS | Jan 12, 2026 | Sell | 79,590 | $17.73 | $1.4M |
| PISKEL KYLE | Jan 12, 2026 | Sell | 4,290 | $18 | $77,000 |
| ROBINS HARLAN S | Jan 6, 2026 | Sell | 10,000 | $16.44 | $160,000 |
| ROBINS CHAD M | Jan 5, 2026 | Sell | 124,998 | $15.59 | $1.9M |
| LO FRANCIS | Jan 2, 2026 | Sell | 3,125 | $16.08 | $50,000 |
| LO FRANCIS | Dec 22, 2025 | Sell | 4,394 | $17.5 | $77,000 |
| LO FRANCIS | Dec 22, 2025 | Sell | 4,394 | $17.5 | $77,000 |
| LO FRANCIS | Dec 15, 2025 | Sell | 113,890 | $15.57 | $1.8M |
| HERSHBERG ROBERT | Dec 10, 2025 | Sell | 22,968 | $16 | $370,000 |
| BENZENO SHARON | Dec 4, 2025 | Sell | 12,604 | $16.85 | $210,000 |
| ROBINS HARLAN S | Dec 4, 2025 | Sell | 10,000 | $16.61 | $170,000 |
| ROBINS HARLAN S | Dec 3, 2025 | Sell | 27,212 | $18.61 | $510,000 |
| ROBINS CHAD M | Dec 1, 2025 | Sell | 124,998 | $18.94 | $2.4M |
| PISKEL KYLE | Nov 28, 2025 | Sell | 162,820 | $19.5 | $3.2M |
| ROBINS CHAD M | Nov 26, 2025 | Sell | 35,736 | $19.68 | $700,000 |
| BENZENO SHARON | Nov 21, 2025 | Sell | 308,477 | $16.91 | $5.2M |
| BENZENO SHARON | Nov 20, 2025 | Sell | 297,925 | $16.54 | $4.9M |
| PISKEL KYLE | Nov 17, 2025 | Sell | 238 | $14.05 | $3,300 |
| ROBINS CHAD M | Nov 12, 2025 | Sell | 1,867 | $15 | $28,000 |
| ROBINS CHAD M | Nov 11, 2025 | Sell | 1,237 | $14.57 | $18,000 |
| ROBINS HARLAN S | Nov 10, 2025 | Sell | 10,000 | $14.82 | $150,000 |
| ROBINS CHAD M | Nov 10, 2025 | Sell | 86,161 | $14.73 | $1.3M |
| PISKEL KYLE | May 16, 2025 | Sell | 1,929 | $8.89 | $17,000 |
| PISKEL KYLE | May 16, 2025 | Sell | 1,929 | $8.89 | $17,000 |
| ROBINS HARLAN S | May 1, 2025 | Sell | 68,412 | $7.35 | $500,000 |
| ROBINS HARLAN S | Mar 24, 2025 | Sell | 1,698 | $9 | $15,000 |
| GRIFFIN MICHELLE RENEE | Mar 13, 2025 | Sell | 36,291 | $7.19 | $260,000 |
| HERSHBERG ROBERT | Mar 12, 2025 | Sell | 53,000 | $7.59 | $400,000 |
| NEUPERT PETER M | Mar 10, 2025 | Sell | 10,000 | $7.05 | $71,000 |
| ROBINS CHAD M | Mar 6, 2025 | Sell | 102,218 | $7.64 | $780,000 |
| GRIFFIN MICHELLE RENEE | Mar 6, 2025 | Sell | 15,664 | $7.94 | $120,000 |
| LO FRANCIS | Mar 5, 2025 | Sell | 13,790 | $6.99 | $96,000 |
| BOBULSKY SUSAN | Mar 5, 2025 | Sell | 26,023 | $6.98 | $180,000 |
| BENZENO SHARON | Mar 5, 2025 | Sell | 41,600 | $6.98 | $290,000 |
| RUBINSTEIN JULIE | Mar 5, 2025 | Sell | 40,044 | $6.98 | $280,000 |
| RUBINSTEIN JULIE | Mar 5, 2025 | Sell | 19,461 | $6.99 | $140,000 |
| ROBINS HARLAN S | Mar 5, 2025 | Sell | 56,053 | $6.99 | $390,000 |
| ROBINS HARLAN S | Mar 5, 2025 | Sell | 40,603 | $6.98 | $280,000 |
| ROBINS CHAD M | Mar 5, 2025 | Sell | 81,206 | $6.98 | $570,000 |
| ROBINS CHAD M | Mar 5, 2025 | Sell | 36,145 | $6.99 | $250,000 |
| LO FRANCIS | Mar 5, 2025 | Sell | 7,085 | $6.98 | $49,000 |
| BENZENO SHARON | Mar 5, 2025 | Sell | 3,065 | $6.99 | $21,000 |
| PISKEL KYLE | Mar 5, 2025 | Sell | 6,964 | $6.99 | $49,000 |
| PISKEL KYLE | Mar 5, 2025 | Sell | 3,103 | $6.97 | $22,000 |
| PISKEL KYLE | Mar 5, 2025 | Sell | 253 | $6.98 | $1,800 |
| ROBINS CHAD M | Feb 20, 2025 | Sell | 99,107 | $8.44 | $840,000 |
| ROBINS CHAD M | Feb 19, 2025 | Sell | 186,080 | $8.46 | $1.6M |
| ROBINS CHAD M | Feb 18, 2025 | Sell | 211,160 | $8.5 | $1.8M |
| ROBINS CHAD M | Feb 14, 2025 | Sell | 158,921 | $8.46 | $1.3M |
| ROBINS CHAD M | Feb 13, 2025 | Sell | 100,287 | $8.44 | $850,000 |
| PISKEL KYLE | Nov 18, 2024 | Sell | 248 | $4.98 | $1,200 |
| Taylor Stacy L | Aug 22, 2024 | Sell | 26,922 | $4.4974 | $120,000 |
FAQ - Insider Transactions
The most recent insider transaction for Adaptive Biotechnologies was conducted by RUBINSTEIN JULIE, who sold 30,941 shares on March 5, 2026 at a price of $16.00 per share.
ROBINS CHAD M has sold the most ADPT stock in the last 2 years, with a total value of $25M.
The total value of insider transactions for Adaptive Biotechnologies in the last 2 years is negative, amounting to -$50M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Adaptive Biotechnologies have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
